REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F907. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,030,499 | +1940.8% | 7,000 | +2233.3% | 0.08% | +1420.0% |
| Q1 2023 | $246,501 | -78.6% | 300 | -81.2% | 0.01% | -80.8% |
| Q4 2022 | $1,154,384 | -20.2% | 1,600 | -23.8% | 0.03% | -3.7% |
| Q3 2022 | $1,447,000 | +377.6% | 2,100 | +320.0% | 0.03% | +170.0% |
| Q3 2021 | $303,000 | – | 500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 56,500 | $33,399,000 | 0.05% |
| JANE STREET GROUP, LLC | 100,400 | $59,349,000 | 0.02% |
| SIMPLEX TRADING, LLC | 12,000 | $7,093,000 | 0.01% |
| JPMORGAN CHASE & CO | 500 | $296,000 | 0.00% |
| Allianz Asset Management GmbH | 600 | $355,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |